New study aims to find safer RA treatment for the heart
NCT ID NCT07554820
First seen Apr 29, 2026 · Last updated Apr 29, 2026
Summary
This study looks at the risk of major heart problems in people with rheumatoid arthritis (RA) who are taking either a combination of tofacitinib and a statin, or a TNF inhibitor. The goal is to see which treatment is safer for the heart. The study involves 120 adults aged 50 and older with moderate to severe RA and at least one heart risk factor, such as high blood pressure or diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shaikh Zayed Hospital, Lahore
RECRUITINGLahore, Punjab Province, 45000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.